Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 9Terminated 4Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 2OTHER 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Hodgkin Disease 6Urinary Bladder Neoplasms 4Melanoma 2Lymphoma 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Seminoma 1Prostatic Neoplasms 1Endodermal Sinus Tumor 1Childhood Solid Tumor 1Carcinoma, Embryonal 1Bladder Adenocarcinoma 1

Interventions

Gemcitabine 25Cisplatin 19pembrolizumab 11avelumab 10Nivolumab 7Mitomycin 6Carboplatin 6apaziquone 5Paclitaxel 5Vinblastine 4Methotrexate 4Doxorubicin 4Docetaxel 4BCG Vaccine 4vofatamab 3durvalumab 3atezolizumab 3Sunitinib 3Standard of Care 3Sorafenib 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Radiation 3Magnetic Resonance Spectroscopy 3Lapatinib 3Cystectomy 3B701 protein, Human herpesvirus 6 3valrubicin 2rucaparib 2enfortumab vedotin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Urinary Bladder Neoplasms × Vinblastine × Clear all
NCT00005047 2017-06-08

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

SWOG Cancer Research Network

Phase 3 Terminated
521 enrolled 18 charts
Genitourinary

Urinary Bladder Neoplasms

NCT00635726 2015-10-08

Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer

Hellenic Oncology Research Group

Phase 2 Terminated
41 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00516750 2013-07-10

Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin

National Cancer Institute (NCI)

Phase 2 Terminated
100 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00003640 2012-03-06

Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
73 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡